FDA says that Female Viagra falls short

June 17th, 2010 - 8:13 pm ICT by Aishwarya Bhatt  

Washington DC, Jun 17 (THAINDIAN NEWS) The Food and Drugs Administration in the United States has said that pills developed by drug manufacturers to boost the sex drive of women have fallen short on two studies.

The drug, which is the female version of the blockbuster sex drive drug Viagra, has so far proved a very difficult venture for drug makers.

However the Food and Drugs Administration is said to be considering flibanserin, a drug from Boerhinger Ingelheim. Flibanserin, which is made for women who have not yet reached their menopause, but nevertheless have lost their sexual drive.

The FDA said that two studies submitted by Boerhinger Ingelheim only showed a slight increase in sexual desire. It said that the studies failed to show significant increase in the sexual desire of the women who used it. But the FDA maintains that nonetheless that was not the primary reason for the studies.

The FDA also said the pink pill from Boerhinger Ingelheim has increased side effects like fainting, dizziness and depression.

Studies have shown that about 40 percent of women suffer from one form of sexual dysfunction or other. And the industry estimates that a ‘Female Viagra’ will have a market share of about $2 billion annually.

Related Stories

Tags: , , , , , , , , , , , , , , , , , ,

Posted in Health |

Subscribe